Mass General Brigham Ventures
Mass General Brigham Ventures
Invests in early-stage companies developing innovative technologies for healthcare and life sciences.
About
What type of investor is Mass General Brigham Ventures?
Mass General Brigham Ventures is the venture capital arm of Mass General Brigham, a leading integrated healthcare system. They focus on investing in early-stage companies that have the potential to transform healthcare delivery, patient outcomes, and medical innovation. Their investments span a range of sectors within life sciences and healthcare technology.
What kind of firm is Mass General Brigham Ventures?
Mass General Brigham Ventures is a Corporate VC.
What is Mass General Brigham Ventures's assets under management?
Mass General Brigham Ventures manages approximately $200M in assets.
Where is Mass General Brigham Ventures based?
Mass General Brigham Ventures is based in Boston, United States.
What sectors does Mass General Brigham Ventures focus on?
Mass General Brigham Ventures focuses on Biotechnology, Medical Devices, Healthcare Technology, Digital Health.
“Nocion Therapeutics Extends Series B Financing to $93 Million to Support Late-Stage Development of Taplucainium in Chronic Cough. Topline results from the ASPIRE Phase 2b study expected in mid-2026 with operating runway through 2027 Series…”
View on RedditSome comments are pulled from public discussions around the web (look for the source icon). Quotes are excerpts; click through to read the full thread.

